We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 16, 2022

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

JAMA Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma
JAMA Oncol 2022 Oct 27;[EPub Ahead of Print], OJ van Not, RJ Verheijden, AJM van den Eertwegh, JBAG Haanen, MJB Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, JB de Groot, GAP Hospers, AM Kamphuis, E Kapiteijn, AM May, MM de Meza, D Piersma, R van Rijn, MA Stevense-den Boer, AAM van der Veldt, G Vreugdenhil, WAM Blokx, MJM Wouters, KPM Suijkerbuijk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading